Dana Foss is Solving the CRISPR Delivery Problem to Advance Therapeutics - a podcast by Synthego

CRISPR has great potential in therapeutics, but CRISPR delivery in vivo remains a challenge. Researcher Dana Foss discusses her lab’s novel approach for specific delivery of CRISPR components in cells and tissues.

Further episodes of CRISPR Cuts

Further podcasts by Synthego

Website of Synthego